Hiroshi Myobudani, Naomi Ushiyama, Ryota Ichinose, Tsuyoshi Takasuka. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AnimalsAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/adverse effectsAntibodies, Monoclonal, Humanized/pharmacologyAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/pharmacologyBreast Neoplasms/drug therapyBreast Neoplasms/geneticsBreast Neoplasms/pathologyCell Transformation, Neoplastic/drug effectsDrug DiscoveryDrug SynergismDrug Therapy, CombinationHumansInfusions, IntravenousRandomized Controlled Trials as TopicReceptor, ErbB-2TrastuzumabTumor Cells, Cultured
Substances： See more » Antibodies, Monoclonal, HumanizedAntineoplastic AgentsERBB2 protein, humanReceptor, ErbB-2pertuzumabTrastuzumab
Year: 2014 PMID： 24531903 DOI： 10.1254/fpj.143.95
Source DB: PubMed Journal: Nihon Yakurigaku Zasshi ISSN： 0015-5691